Tag Archives: Progress

IN BRIEF: Phase III Clinical Trials of  Multiple Sclerosis Drug Alemtuzumab Show Progress

IN BRIEF: Phase III Clinical Trials of Multiple Sclerosis Drug Alemtuzumab Show Progress

IN BRIEF: Phase III Clinical Trials of ┬áMultiple Sclerosis Drug Alemtuzumab Show Progress We have noted the great potential of the┬áMultiple Sclerosis Drug Alemtuzumab in a previous posts [1] Note that current research see it prescribed for the Relapsing Remitting (RRMS) form, which is indeed what the clinical trials mentioned …Read the Rest

Progress in the fight against superbugs (ScienceDaily)

Progress in the fight against superbugs (ScienceDaily)

MediNewsDigest: A technique has been developped at the U. Tel Aviv University’s Department of Chemistry  to beat the “superbugs”. The approach  uses the defense mechanism of bacteria resistant to antibiotics  against itself.  Follow the links to the Israel21c and  ScienceDaily article

© 2013-2019 Medical News Digest All Rights Reserved